This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Chronic Kidney Disease or Chronic Kidney Disease on Hemodialysis
and you are
over 18
years old
3
This is a trial in the final phase before the treatment is released on the market.
Show me locations

The purpose

The study aims to evaluate the efficacy and safety of sevelamer carbonate in reducing serum phosphorus and serum lipids (total and LDL-cholesterol) in Chronic Kidney Disease Patients on dialysis.

Provided treatments

  • Drug: Placebo
  • Drug: Sevelamer carbonate
Tris trial is registered with FDA with number: NCT01736150. The sponsor of the trial is Genzyme, a Sanofi Company and it is looking for 205 volunteers for the current phase.
Official trial title:
A Randomized, Double-Blind, Placebo-Controlled, Dose-Titration Study of Sevelamer Carbonate in CKD Patients on Hemodialysis